Pancreatic Cancer Research

ResearcherLanzhou University Second HospitalActive in the last 2 years

Ru He

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5100972270. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Cordycepin inhibits pancreatic cancer progression and enhances gemcitabine sensitivity by targeting the CDK2/E2F2 axis to modulate TNNI2 expression. Co-author DOI 10.1016/j.bcp.2026.118299↗
  2. Long non-coding RNA MIR4435-2HG promotes pancreatic cancer progression by regulating ABHD17C through sponging miR-128-3p. Co-author DOI 10.21037/tcr-24-51↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wence Zhou · 2 shared papers, 2024–2026 · strength 0.69
  2. Wenkai Jiang · 1 shared paper, 2026 · strength 0.43
  3. Huaqing Shi · 1 shared paper, 2024 · strength 0.26
  4. Zhou Chen · 1 shared paper, 2024 · strength 0.26
  5. Shi Dong · 1 shared paper, 2024 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.